BGI: Five new crest virus detection products of the subsidiary have obtained EU certification

BGI: Five new crest virus detection products of the subsidiary have obtained EU certification
Sauna Night News (Reporter Li Yunqi) On April 29, the listed company Huada Gene announced that five new coronaviruses (hereinafter referred to as “European Medicine”) of its wholly-owned subsidiary BGI Europe A / S (hereinafter referred to as “European Medicine”)”New Crown”) testing products have recently completed the EU CE certification.According to the BGI announcement, the 5 new coronavirus detection products belonging to European medicine include 2 nucleic acid detection reagent products and 3 antibody detection reagent products.BGI said that the completion of CE certification of the above five new crown detection products will help meet the clinical needs of customers in the international market, further enhance the company’s comprehensive competitiveness of products, and help prevent and control the pneumonia outbreak of new coronavirus infections worldwide.The actual sales of the above-mentioned products depend on the testing needs involved in the prevention and control of pneumonia outbreaks caused by new coronaviruses. The company is currently unable to predict its impact on the company’s future performance.Data show that in the first quarter of 2020, BGI Gene’s operating income was 7.90,000 yuan, an annual increase of 35.78%, the net profit attributable to shareholders of listed companies.4 ten percent, an annual increase of 42.59%.According to a quarterly report of BGI, due to the impact of the new coronavirus pneumonia epidemic, the market’s demand for new coronavirus detection kits has grown rapidly.The company’s production capacity and testing throughput, the company’s infection prevention and control business and precision medical testing integrated solution business in the reporting period achieved rapid growth in the report.Sauna, Yenet Li Yunqi editor Yue Caizhou proofreading Li Ming